FridayJun 06, 2025 3:47 pm

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Leads with Vision and Cutting-Edge Gear Amid Golf’s Resurgence

Newton Golf Company (NASDAQ: NWTG) is riding the wave of golf’s renewed popularity, driven by increasing diversity, inclusivity, and innovation within the sport. With more than 47 million Americans engaging in golf activities in 2024, the sport has evolved into a dynamic, accessible pastime. Newton Golf is capitalizing on this momentum by developing performance-enhancing products, including those in its Newton Motion Shaft and Gravity Putter lines, showcased at the 2025 PGA Show. The company’s strategic focus combines cutting-edge technology and community engagement, with products designed to optimize swing dynamics, improve putting accuracy and enhance performance and enjoyment for golfers of all…

Continue Reading

FridayJun 06, 2025 3:16 pm

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Center of Critical Materials, Innovation

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself for growth amid strong palladium market dynamics, driven by constrained supply and continued industrial demand. With palladium essential in automotive, electronics, and emerging clean energy applications, the company is advancing the Waterberg Project in South Africa—one of the largest undeveloped primary palladium and platinum projects globally. In partnership with Anglo American Platinum Limited, PLG is also investing in future-focused innovation through Lion Battery Technologies, which explores the use of platinum and palladium in next-generation lithium battery technologies. Among the few companies combining traditional mining development with tech-driven diversification, Platinum…

Continue Reading

FridayJun 06, 2025 1:55 pm

QualityStocksNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings… The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers…

Continue Reading

FridayJun 06, 2025 9:35 am

QualityStocksNewsBreaks – Authentic Holdings (OTC: AHRO) Subsidiary Maybacks Signs Streaming Deal With Plex

Authentic Holdings (OTC: AHRO) announced that its wholly owned subsidiary, Maybacks Global Entertainment, LLC, has entered into a licensing and distribution agreement with Plex GmbH to bring its iDreamCTV network brands—Toro TV, Comfy TV, Winnie’s World, and iCowboy—to a global streaming audience. The partnership leverages Plex’s AVOD and FAST channel infrastructure to monetize and distribute Maybacks’ content across its 25 million-user platform. Following its acquisition of Goliath Motion Picture Promotions, Maybacks is pivoting from traditional film sales to building proprietary media brands with scalable digital reach. To view the full press release, visit https://ibn.fm/hnCSv About Authentic Holdings Authentic Holdings combines…

Continue Reading

ThursdayJun 05, 2025 1:38 pm

QualityStocksNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic payloads. The company unveiled promising new data on its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology (“ASCO”) Annual Meeting. The announcement reads, “Calidi has previously demonstrated its pioneering efforts in developing an enveloped form of its proprietary oncolytic virus that is significantly more resistant to immune clearance than non-enveloped forms, allowing for systemic delivery and efficacy in syngeneic tumor-bearing pre-clinical models. Calidi has further advanced this technology with CLD-401, its first…

Continue Reading

ThursdayJun 05, 2025 10:00 am

QualityStocksNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Receives Italian Clearance for Option to Acquire Biotech Firm Pincell

Scinai Immunotherapeutics (NASDAQ: SCNI) announced it has received regulatory clearance under Italy’s Golden Power regulation to proceed with its option to acquire 100% of Pincell S.r.l., an Italian biotech company. The approval, issued by Italy’s Coordination Group and Ministry of Health, supports Scinai’s strategic move to expand its inflammation and immunology pipeline. Pincell’s lead asset, PC111—a monoclonal antibody targeting the Fas/FasL pathway—holds Orphan Drug Designation in Pemphigus and is being developed for severe skin disorders. The acquisition remains subject to final conditions, including a €12 million grant decision expected later this summer. To view the full press release, visit https://ibn.fm/qoRQ1…

Continue Reading

ThursdayJun 05, 2025 9:50 am

QualityStocksNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit

CNS Pharmaceuticals (NASDAQ: CNSP) announced that Chief Medical Officer Sandra Silberman, M.D., Ph.D., will present at the Brain Tumor Biotech Summit hosted by Lenox Hill Hospital’s Department of Neurosurgery on June 5, 2025. Her presentation, titled "The Future and Promise of TPI 287," will highlight CNS’s brain-penetrating taxane candidate, which has shown efficacy in glioblastoma patients, including 3 complete and 9 partial responses in a Phase 1 trial. TPI 287, which has FDA Orphan Drug Designation for gliomas, pediatric neuroblastoma, and progressive supranuclear palsy, may offer a breakthrough in treating CNS tumors by effectively crossing the blood-brain barrier. To view…

Continue Reading

ThursdayJun 05, 2025 9:30 am

QualityStocksNewsBreaks – Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) Reports Promising Copper Targets at Epworth Project in Nunavut

Aston Bay (TSX.V: BAY) (OTCQB: ATBHF) has released results from its 2024 exploration program at the Epworth Project in Nunavut, highlighting surface samples with copper grades up to 61.2% and silver up to 5,600 g/t. The company’s MobileMT airborne geophysical survey identified extensive conductive bodies—interpreted as potential reductants such as pyrite or graphite—within the Proterozoic Recluse Group rocks. CEO Thomas Ullrich stated these findings support the potential for a large-scale, sediment-hosted copper system, drawing parallels to successful models used in Central Africa and Aston Bay’s Storm Copper Project. Targets span tens of kilometers and are largely within 300 meters of…

Continue Reading

ThursdayJun 05, 2025 9:20 am

QualityStocksNewsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Allocate Solar Project Revenue to Bitcoin Treasury Strategy

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has taken its first step toward implementing a Bitcoin treasury strategy by committing net revenue from its 3.79 MW Geddes Solar Power Project to Bitcoin purchases. This initiative places SolarBank among the early renewable energy companies integrating digital assets into corporate finance. The Geddes Project, built on a repurposed landfill, is expected to begin operations by the end of June 2025. CEO Dr. Richard Lu described the move as a strategic blend of stable energy cash flow and Bitcoin’s appreciation potential, with future expansions of the…

Continue Reading

ThursdayJun 05, 2025 9:00 am

QualityStocksNewsBreaks – ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Featured in Editorial Highlighting Next Wave of Scalable Gold Producers

ESGold (CSE: ESAU) (OTCQB: ESAUF) today announced its inclusion in a NetworkNewsWire (“NNW”) editorial spotlighting the emerging class of near-term gold producers positioned for institutional interest. As gold prices climbed above $3,000 per ounce in May 2025, investor demand has shifted toward companies offering leverage, scalability and recurring revenue—traits ESGold is designed to deliver. With a clean balance sheet and scalable model, ESGold is gaining attention as central banks increase gold reserves and institutional capital seeks stronger exposure to the metal’s long-term upside. To view the full press release, visit https://ibn.fm/vbgsS About ESGold Corp. ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) (FSE: Z7D) is…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered